S

Sibylla Biotech

22 employees

Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Pharmaceutical

Date founded

2017

Funding rounds raised

Total raised

$23M

from 6 investors over 6 rounds

S

Sibylla Biotech raised $23M on October 4, 2022

Investors: 3B Future Health Fund, VI Partners AG, V-Bio Ventures, Indaco Venture Partners, Seroba-Kernel Ltd (Ireland) and Claris Ventures SGR SpA

FAQ